Ranbaxy Laboratories Limited - SWOT Analysis company profile is the essential source for top-level company data and information. Ranbaxy Laboratories Limited - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Ranbaxy Laboratories (Ranbaxy), a subsidiary of Daiichi Sankyo, is the largest generic pharmaceutical company in India. It is engaged in the manufacture and trade of formulations, active pharmaceuticals ingredients (API) and intermediates, generics, drug discovery and consumer health care products. It also focuses on research and development activities primarily in India. The company operates in India, Europe, North America and Asia Pacific. It is headquartered in Gurgaon, India and employed 13,420 people as of December 31, 2010. The company recorded revenues of INR89,607.7 million ($1,953.4 million*) during the financial year (FY) ended December 2010, an increase of 18% over FY2009. The operating profit of the company was INR29,363.8 million ($640.1 million) during FY2010, as compared to an operating profit of INR13,484.2 million ($294 million*) in 2009. The net profit was INR14,967.5 million ($326.3 million*) in FY2010, as compared to a net profit of INR2,964.9 million ($64.6 million*) in FY2009. * Calculated using the constant currency conversion rate of INR1 = $0.0218 for the financial year ended December 31, 2010.
Scope of the Report
Provides all the crucial information on Ranbaxy Laboratories Limited required for business and competitor intelligence needs
Contains a study of the major internal and external factors affecting Ranbaxy Laboratories Limited in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Ranbaxy Laboratories Limited
Data is supplemented with details on Ranbaxy Laboratories Limited history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Ranbaxy Laboratories Limited
Reasons to Purchase
Support sales activities by understanding your customers’ businesses better
Understand prospective partners and suppliers
Keep fully up to date on your competitors’ business structure, strategy and prospects
Obtain the most up to date company information available